Effect of diet on serotonergic neurotransmission in depression

Neurochemistry International

Volumn 62, Issue 3, 2013, Pages 324-329

  Shabbir, Faisal ^a   Patel, Akash ^a   Mattison, Charles ^a   Bose, Sumit ^a   Krishnamohan, Raathathulaksi ^a   Sweeney, Emily ^a   Sandhu, Sarina ^a   Nel, Wynand ^a   Rais, Afsha ^a   Sandhu, Ranbir ^a   Ngu, Nguasaah ^a   Sharma, Sushil ^a  

^a SAINT JAMES SCHOOL OF MEDICINE   (Anguilla)

Author keywords

Depression; Hypertension; Melatonin; Obesity; Parkinson's disease; Pyridoxal phosphate; Seizures; Serotonin; Sleep; Tryptophan

Indexed keywords

DOMOIC ACID; INSULIN; PENTETRAZOLE; PICROTOXIN; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ALZHEIMER DISEASE; ANXIETY DISORDER; BLOOD BRAIN BARRIER; CHRONIC PAIN; DEPRESSION; DIET; DOPAMINERGIC NERVE CELL; DRUG DEPENDENCE; EPILEPSY; FRUIT; HUMAN; INSULIN RESPONSE; MAJOR DEPRESSION; MOTOR DYSFUNCTION; NEOPLASM; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC NERVE; PARKINSON DISEASE; PHOTOTHERAPY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEASONAL AFFECTIVE DISORDER; SEROTONINERGIC SYSTEM; SUBSTANTIA NIGRA; VEGETABLE;

EID: 84873366393     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.12.014     Document Type: Short Survey

References (71)

1. A. Ajjimaporn, J. Swinscoe, S. Shavali, P. Govitrapong, and M. Ebadi Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells Brain Res. Bull. 67 2005 466 475 (Pubitemid 41416741)
2. A. Ajjimaporn, P. Phansuwan-Pujito, M. Ebadi, and P. Govitrapong Zinc protects SK-N-SH cells from methamphetamine-induced alpha-synuclein expression Neurosci. Lett. 419 2007 59 63 (Pubitemid 46711138)
3. A. Ajjimaporn, S. Shavali, M. Ebadi, and P. Govitrapong Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity Brain Res. Bull. 77 2008 361 366
4. S.F. Ali, J.L. Martin, M.D. Black, and Y. Itzhak Neuroprotective role of melatonin in methamphetamine- and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity Ann. NY Acad. Sci. 890 1999 119 (Pubitemid 30040370)
5. Bose, S.R., Rohan, K.J., Sleemi, A., Langenberg, P., Khabazghazvini, B., Vaswani, D., Patel, F., Balis, T., Johnson, M., Reeves, G.M., Postolache, T.T., 2012. SAD patients' activities during light therapy sessions. Reading is associated with better outcome. JNMD (ACCEPTED).
6. K. Dakshinamurti, S.K. Sharma, and J.D. Geiger Neuroprotective actions of pyridoxine Biochim. Biophys. Acta 1647 2003 225 229 (Pubitemid 38234660)
7. 6 and hypertension Ann. NY Acad. Sci. 585 1990 241
8. K. Dakshinamurti, C.S. Paulose, M. Viswanathan, Y.L. Siow, S.K. Sharma, and B. Bolster Neurobiology of pyridoxine Ann. NY Acad. Sci. 585 1990 128 144 (Pubitemid 20175893)
9. K. Dakshinamurti, S.K. Sharma, and D. Bonke Influence of B-vitamins on binding properties of serotonin receptors in the CNS of rats Klin. Wochenschr. 68 1990 142 145 (Pubitemid 20044369)
10. K. Dakshinamurti, S.K. Sharma, and K.J. Lal Pyridoxine deficiency Anim. Models Neurol. Dis. Neuromethods 22 1992 299 327
11. K. Dakshinamurti, S.K. Sharma, M. Sundaram, and T. Watanabe Hippocampal changes in developing postnatal mice following intra-uterine exposure to domoic acid J. Neurosci. 13 1993 4486 4495 (Pubitemid 23299967)
12. A.B. Ettinger, M. Deborah, D.M. Weisbrot, E. Edith, E.E. Nolan, K.D. Gadow, S.A. Vitale, M.R. Andriola, N.J. Lenn, G.P. Novak, and B.P. Hermann Symptoms of depression and anxiety in pediatric epilepsy patients Epilepsia 39 1998 595 599 (Pubitemid 28265426)
13. E. Fosslien Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation Ann. Clin. Lab. Sci. 31 2001 25 67 (Pubitemid 32097212)
14. E. Fuller-Thomson, and S. Brennenstuhl The association between depression and epilepsy in a nationally representative sample Epilepsia 50 2009 1051 1058
15. K. Honma Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation? Brain Nerve 64 2012 639 646
16. A.J. Hutchinson, R.L. Hudson, and M.L. Dubocovich Genetic deletion of MT (1) and MT (2) melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN mice J. Pineal Res. 53 2012 399 409
17. S.Z. Imam, J. el-Yazal, G.D. Newport, Y. Itzhak, J.L. Cadet, W. Slikker Jr., and S.F. Ali Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts Ann. NY Acad. Sci. 939 2001 366 380 (Pubitemid 32620088)
18. S. Kaewsuk, K. Sae-ung, P. Phansuwan-Pujito, and P. Govitrapong Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain Neurochem. Int. 55 2009 397 405
19. A.M. Kanner, A.M. Kozak, and M. Frey The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav. 1 2000 100 105
20. A.M. Kanner Depression and epilepsy: a new perspective on two closely related disorders Epilepsy Curr. 6 2006 141 146
21. A.M. Kanner Depression and epilepsy: a bidirectional relation? Epilepsia 52 2011 21 27
22. P. Kongsuphol, S. Mukda, C. Nopparat, A. Villarroel, and P. Govitrapong Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells J. Pineal Res. 46 2008 199 206
23. K.M. Koorengevel, C.M. Marijke, Gordijn., G.M. Beersma Domien, Y. Meesters, J.A. den Boer, R.H. van den Hoofdakker, and S. Daan Extraocular light therapy in winter depression: a double blind placebo-controlled study Biol Psych 50 9 2001 691 698 (Pubitemid 33043772)
24. 6 Clin. Exp. Hypertens. 15 1993 489 500 (Pubitemid 23115262)
25. A.J. Levitt, R.W. Lam, and R. Levitan A Comparison of open treatment of seasonal major and minor depression with light therapy J. Affect. Disord. 71 2000 243 248
26. E.J. Manzana, W.J. Chen, and T.H. Champney Acute melatonin and para-chloroamphetamine interactions on pineal, brain and serum serotonin levels as well as stress hormone levels Brain Res. 909 2001 127 137 (Pubitemid 32710126)
27. C.R. Markus, B. Olivier, and E.H. de Haan Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects Am. J. Clin. Nutr. 75 2002 1051 1056 (Pubitemid 34547535)
28. S. Masubuchi, S. Honma, H. Abe, K. Ishizaki, M. Namihira, M. Ikeda, and K. Honma Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor activity rhythm in rats Eur. J. Neurosci. 12 2000 4206 4214 (Pubitemid 32037831)
29. M. Mula Depression in epilepsy: mechanisms and therapeutic approach Ther. Adv. Neurol. Disord. 2 2009 337 344
30. R.J. Naftalin, P. Cunningham, and I. Afzal-Ahmed Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte d-glucose transport Br. J. Pharmacol. 142 2004 594 608 (Pubitemid 38869874)
31. C. Nopparat, J.E. Porter, M. Ebadi, and P. Govitrapong The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy J. Pineal Res. 49 2010 382 389
32. K. Permpoonputtana, and P. Govitrapong The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines Neurotox. Res. 23 2013 189 199
33. E. Pineda, D. Shin, R. Sankar, and A.M. Mazarati Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid and neuroinflammatory mechanisms Epilepsia 51 2010 110 114
34. R.J. Reiter, L.C. Manchester, and D.X. Tan Neurotoxins: free radical mechanisms and melatonin protection Curr. Neuropharmacol. 8 2010 194 210
35. I.H. Richard, M.P. McDermott, R. Kurlan, J.M. Lyness, P.G. Como, N. Pearson, S.A. Factor, J. Juncos, Serrano, C. Ramos, M. Brodsky, C. Manning, L. Marsh, L. Shulman, H.H. Fernandez, K.J. Black, M. Panisset, C.W. Christine, W. Jiang, C. Singer, S. Horn, R. Pfeiffer, D. Rottenberg, J. Slevin, L. Elmer, D. Press, H.C. Hyson, and W. McDonald SAD-PD study group. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease Neurology 78 2012 1229 1236
36. N.E. Rosenthal, D.A. Sack, J.C. Gillin, A.J. Lewy, F.K. Goodwin, Y. Davenport, P.S. Mueller, D.A. Newsome, and T.A. Wehr Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy Arch. Gen. Psychiatry 41 1984 72 80 (Pubitemid 14215339)
37. S. Shamim, G. Hasler, C. Liew, S. Sato, and W.H. Theodore Temporal lobe epilepsy, depression, and hippocampal volume Epilepsia 50 2009 1067 1071
38. S.K. Sharma, B. Bolster, M. Viswanathan, and K. Dakshinamurti Effects of pyridoxine deficiency on picrotoxin-induced seizure activity in the rat Ann. NY Acad. Sci. 585 1990 543 548 (Pubitemid 20175945)
39. S.K. Sharma, B. Bolster, and K. Dakshinamurti Effect of pyridoxine on nociceptive thalamic unit activity Ann. NY Acad. Sci. 585 1990 549 553 (Pubitemid 20175946)
40. S.K. Sharma, and K. Dakshinamurti Seizure activity in pyridoxine-deficient adult rats Epilepsia 33 1992 235 247
41. S.K. Sharma, and K. Dakshinamurti Suppression of domoic acid-induced seizures by 8-(OH)-DPAT J. Neural Trans. 93 1993 87 89
42. S.K. Sharma, and K. Dakshinamurti Effects of serotonergic agents on plasma prolactin levels in pyridoxine-deficient adult male rats Neurochem. Res. 19 1994 687 692 (Pubitemid 24154232)
43. S.K. Sharma, B. Bolster, and K. Dakshinamurti Picrotoxin and pentylene tetrazole induced seizure activity in pyridoxine-deficient rats J. Neurol. Sci. 121 1994 1 9 (Pubitemid 24025238)
44. 6 vitamers and pyridoxic acid in biological samples J. Chromatogr. 578 1992 45 51
45. S.K. Sharma, W. Selvamurthy, and K. Dakshinamurti Effect of environmental neurotoxins in the developing brain Biometeorology 2 1993 447 455
46. S. Sharma, and M. Ebadi Metallothioneins as early & sensitive biomarkers of redox signaling in neurodegenerative disorders J. Inst. Integr. Omics Appl. Biotechnol. (IIOAB J.) 2 2011 98 106
47. S. Sharma, and M. Ebadi Therapeutic potential of metallothioneins as antiinflammatory agents in polysubstance abuse J. Inst. Integr. Omics Appl. Biotechnol. IIOAB 2 2011 50 61
48. S. Shavali, B. Ho, P. Govitrapong, S. Sawlom, A. Ajjimaporn, S. Klongpanichapak, and M. Ebadi Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid Brain Res. Bull. 64 2005 471 479 (Pubitemid 40082497)
49. L. Sher, J.R. Matthews, E.H. Turner, T.T. Postolache, K.S. Katz, and N.E. Rosenthal Early response to light therapy partially predicts long-term antidepressant effects in patients with seasonal affective disorder J. Psychiatry Neurosci. 26 2001 336 338 (Pubitemid 32912428)
50. N.K. Singhal, G. Srivastava, S. Agrawal, S.K. Jain, and M.P. Singh Mol. Neurobiol. 45 2012 186 199
51. C. Sohn, and R.W. Lam Update on the biology of seasonal affective disorder CNS Spectr. 10 2005 635 646 (Pubitemid 41232546)
52. J.L. Stewart, D.N. Towers, J.A. Coan, and J.B. John The oft-neglected role of parietal EEG asymmetry and risk for major depressive disorder Psychophysiology 48 2011 82 95
53. J.W. Stewart, F.M. Quitkin, M. Terman, and J.S. Terman Is seasonal affective disorder a variant of atypical depression? differential response to light therapy Psych. Res. 33 1990 101 214
54. W. Suwanjang, P. Phansuwan-Pujito, P. Govitrapong, and B. Chetsawang The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells J. Pineal Res. 48 2010 94 101
55. A.W. Thompson, J.W. Miller, W. Katon, N. Chaytor, and P. Ciechanowski Sociodemographic and clinical factors associated with depression in epilepsy Epilepsy Behav. 14 2009 655 660
56. J. Tocharus, C. Khonthun, S. Chongthammakun, and P. Govitrapong Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines J. Pineal Res. 48 2010 347 352
57. A.E. Vaaler, G. Morken, V.C. Iversen, D. Kondziella, and O.M. Linaker Acute unstable depressive syndrome (AUDS) is associated more frequently with epilepsy than major depression BMC Neurology 10 2010 67
58. A. Virmani, F. Gaetani, S. Imam, Z. Binienda, and S. Ali Possible mechanism for the neuroprotective effects of l-carnitine on methamphetamine- evoked neurotoxicity Ann. NY Acad. Sci. 993 2003 197 207 (Pubitemid 36808451)
59. 2 adrenoreceptor activity in pyridoxine-deficient rat model of hypertension Neurosci. Lett. 111 1990 201 205 (Pubitemid 20102142)
60. M. Viswanathan, Y.L. Siow, C.S. Paulose, and K. Dakshinamurti Pineal indoleamine metabolism in pyridoxine-deficient rats Brain Res. 473 1988 37 42 (Pubitemid 19008208)
61. N. Vogelzangs, S.B. Kritchevsky, A.T.F. Beekman, A.B. Newman, S. Satterfield, E.M. Simonsick, K. Yaffe, T.B. Harris, and B.W.J.H. Penninx Depressive symptoms and change in abdominal obesity among older persons Arch. Gen. Psychiatry 65 2008 1386 1393
62. N. Vogelzangs, H.E. Duivis, A.T.F. Beekman, C. Kluft, J. Neuteboom, W. Hoogendijk, J.H. Smit, P. deJonge, and J.H. Penninx Association of depressive disorders, depression characteristics and antidepressant medication with inflammation Transl. Psychiatry 2 2012 e79
63. M. Voracek, and U.S. Tran Dietary tryptophan intake and suicide rate in industrialized nations J. Affect. Disord. 98 2007 259 262 (Pubitemid 46149059)
64. T.A. Wehr, W.C. Duncan Jr., L. Sher, D. Aeschbach, P.J. Schwartz, E.H. Turner, T.T. Postolache, and N.E. Rosenthal A circadian signal of change of season in patients with seasonal affective disorder Arch. Gen. Psychiatry 58 2001 1108 1114 (Pubitemid 33121501)
65. A. Westrin, and R.W. Lam Long-term and preventative treatment for seasonal affective disorder CNS Drugs 21 2007 901 909 (Pubitemid 47557105)
66. J.B.W. Williams, M.J. Link, N.E. Rosenthal, L. Amira, and M. Terman Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH SAD) Revised ed. 1994 New York State Psychiatr. Inst New York
67. W. Wisessmith, P. Phansuwan-Pujito, P. Govitrapong, and B. Chetsawang Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells J. Pineal Res. 46 2009 433 440
68. R.J. Wurtman, F. Hefti, and E. Melamed Precursor control of neurotransmitter synthesis Pharmacol. Rev. 32 1980 315 335
69. R.J. Wurtman, and J.J. Wurtman Brain serotonin, carbohydrate-craving, obesity and depression Obes. Res. 4 1995 477S 480S
70. S.N. Young, and S. Gauthier Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid J. Neurol. Neurosurg. Psychiatry 44 1981 323 327
71. L. Yu, C.F. Cherng, and C. Chen Melatonin in concentrated ethanol and ethanol alone attenuate methamphetamine induced dopamine depletions in C57BL/6J mice J. Neural. Transm. 109 2002 1477 1490 (Pubitemid 36057057)